激光治疗与期待治疗用于单绒毛膜双胎选择性胎儿生长受限的系统综述
该系统综述纳入6项研究共299例妊娠,比较激光治疗与期待治疗用于单绒毛膜双胎选择性胎儿生长受限。激光治疗与FGR胎儿死亡风险升高相关(RR 2.5),新生儿死亡和分娩孕周无差异,适合胎儿的异常神经影像减少(RR 0.25),神经发育结局无差异但数据有限。
要点
- 激光治疗与FGR胎儿死亡风险升高相关(RR 2.5,95%CI 1.43-4.37)。
- 激光治疗与适合胎儿异常神经影像减少相关(RR 0.25,95%CI 0.07-0.97)。
- 新生儿死亡和分娩孕周无差异,神经发育结局无差异但数据有限。
核心结论
- 激光治疗导致更多FGR胎儿死亡,但未改变分娩孕周或新生儿死亡率。
- 文献存在异质性且偏倚水平高,需要针对II型sFGR的随机试验并纳入长期神经结局。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE和Cochrane数据库。
- 纳入6项研究共299例妊娠,其中1项随机研究,其余为回顾性队列。
- 使用GRADE评估质量,采用随机效应模型生成相对风险。
主要发现
- 激光治疗与FGR胎儿死亡风险升高相关(RR 2.5,95%CI 1.43-4.37,p=0.001,I²=48%)。
- 新生儿死亡和分娩孕周无差异。
- 激光治疗与适合胎儿异常神经影像减少相关(RR 0.25,95%CI 0.07-0.97,p=0.05)。
- 神经发育结局无差异,但数据有限。
局限性
- 文献存在异质性(FGR胎儿死亡分析I²=48%)。
- 偏倚水平高。
- 神经发育结局数据有限。
- 需要针对II型sFGR的随机试验并纳入长期神经结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Selective fetal growth restriction (sFGR) complicates 10%-26% of monochorionic twins. Treatment options include cord coagulation, expectant management, and fetoscopic laser photocoagulation. This review compared laser to expectant management for situations when cord coagulation is not an option. The MEDLINE, EMBASE, and Cochrane databases were queried for studies that compared laser to expectant management for sFGR. GRADE was used to assess quality prior to meta-analysis. A random-effects model was used to generate relative risks. Six studies were included, encompassing 299 pregnancies. One study was randomized and the remainder were retrospective cohorts. Laser is associated with more fetal deaths of the FGR twin compared to expectant management (risk ratio [RR] 2.5, 95% confidence interval [CI] 1.43-4.37, p = 0.001, I2 = 48%). Neonatal deaths and gestational age at delivery did not differ. Laser was associated with decreased abnormal neuroimaging in the AGA twin (RR 0.25, 95% CI 0.07-0.97, p = 0.05). Neurodevelopmental outcomes did not differ, although these data are limited. Laser causes more fetal deaths of the FGR twin without altering gestational age at delivery or rates of neonatal death. The literature is heterogeneous and the level of bias is high. Randomized trials that address laser for type II sFGR are needed and should include long-term neurological outcomes.
引用
- Buskmiller C, Munoz JL, Cortes MS, et al. Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review. Prenat Diagn. 2023. PMID: 36991554. doi:10.1002/pd.6348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。